Analysed VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) News Sources
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
07-07-2026
yahoo.com
VNDA Stock Gains After-Hours As FDA Grants Rare Pediatric Disease Designation For Experimental Therapy
08-07-2026
stocktwits.com
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
10-07-2026
yahoo.com
Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe
16-07-2026
yahoo.com
NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
22-08-2026
yahoo.com
What is the current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is $5.09.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is $0.05.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is 0.9921%.
What is the most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is .
SEC-8K** Filing Available For VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.